Cancer in multiple sclerosis patients following prolonged exposure to disease-modifying therapies (DMTs): a systematic review and meta-analysis

被引：0
|
作者：
Vasileios Giannopapas [1 ]
Vassiliki Smyrni [2 ]
Dimitrios K. Kitsos [1 ]
Maria Ioanna Stefanou [1 ]
Aikaterini Theodorou [1 ]
John S. Tzartos [1 ]
Georgios Tsivgoulis [1 ]
Sotirios Giannopoulos [1 ]
机构：
[1] National & Kapodistrian University of Athens,Second Department of Neurology, Attikon University Hospital
[2] University of West Attica,Department of Physical Therapy
来源：
Journal of Neurology | 2025年 / 272卷 / 2期
关键词：
Multiple sclerosis; Autoimmune diseases; Cancer; Malignancy; Disease-modifying therapies;
D O I：
10.1007/s00415-024-12882-4
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Factors affecting adherence to disease-modifying therapies in multiple sclerosis: systematic review
    Francesca Washington
    Dawn Langdon
    Journal of Neurology, 2022, 269 : 1861 - 1872
  • [22] Factors affecting adherence to disease-modifying therapies in multiple sclerosis: systematic review
    Washington, Francesca
    Langdon, Dawn
    JOURNAL OF NEUROLOGY, 2022, 269 (04) : 1861 - 1872
  • [23] Comparative safety of high-efficacy disease-modifying therapies in relapsing–remitting multiple sclerosis: a systematic review and network meta-analysis
    Katarzyna Śladowska
    Paweł Kawalec
    Przemysław Holko
    Oktawia Osiecka
    Neurological Sciences, 2022, 43 (9) : 5479 - 5500
  • [24] The Effect of Disease Modifying Therapies on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis
    Tsivgoulis, Georgios
    Katsanos, Aristeidis H.
    Grigoriadis, Nikolaos
    Hadjigeorgiou, Georgios M.
    Heliopoulos, Ioannis
    Papathanasopoulos, Panagiotis
    Kilidireas, Constantinos
    Voumvourakis, Konstantinos
    Dardiotis, Efthimios
    PLOS ONE, 2015, 10 (12):
  • [25] Disease modifying therapies in relapsing-remitting multiple sclerosis: A systematic review and network meta-analysis
    Liu, Zhuoyi
    Liao, Qiao
    Wen, Haicheng
    Zhang, Yihao
    AUTOIMMUNITY REVIEWS, 2021, 20 (06)
  • [26] Disease-modifying therapies for multiple sclerosis
    De Angelis, Floriana
    John, Nevin A.
    Brownlee, Wallace J.
    BMJ-BRITISH MEDICAL JOURNAL, 2018, 363
  • [27] Multiple sclerosis and disease-modifying therapies
    Minen, Mia T.
    Karceski, Steven
    NEUROLOGY, 2011, 77 (04) : E26 - E26
  • [28] Comparison of ofatumumab and other disease-modifying therapies for relapsing multiple sclerosis: a network meta-analysis
    Samjoo, Imtiaz A.
    Worthington, Evelyn
    Drudge, Christopher
    Zhao, Melody
    Cameron, Chris
    Haering, Dieter A.
    Stoneman, Dee
    Klotz, Luisa
    Adlard, Nicholas
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2020, 9 (18) : 1255 - 1274
  • [29] Adherence to disease-modifying therapies in patients with multiple sclerosis
    Koltuniuk, Aleksandra
    Rosinczuk, Joanna
    PATIENT PREFERENCE AND ADHERENCE, 2018, 12 : 1557 - 1565
  • [30] Disease-modifying therapies for multiple sclerosis
    John R. Corboy
    Douglas S. Goodin
    Elliot M. Frohman
    Current Treatment Options in Neurology, 2003, 5 (1) : 35 - 54
12345